← Eichor
Study identifier: NCT06799936 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

A Communication-Priming Intervention to Improve Shared Decision-Making Between Older Adults With Advanced CKD and Clinicians

Condition: Chronic Kidney Disease Stage 4 · Chronic Kidney Disease Stage 5  ·  Sponsor: The University of Hong Kong

PhaseNA
Planned participants280
Who can joinAll sexes, 65 Years to no upper limit
Healthy volunteersNo

About this study

To achieve the goal of reaching consensus about the preferred treatment option that best aligns with the goals and values of patients, the investigators developed a 'CKD Jumpstart- Tips" priming tool tailored for older adults with advanced CKD that is based on communication principles from VitalTalk and Elwyn's goal-based SDM model. The investigators hypothesize that compared with patients in the usual care group, patients in the 'CKD Jumpstart- Tips' intervention group will have: 1. increased level of shared decision-making (observer-based and patient-reported), 2. improved quality of communication, 3. increased patient involvement in decision-making, 4. lower decisional conflict, 5. lower decision regret, 6. decreased time to decision, 7. improved adherence to treatment choice, and 8. improved health-related quality-of-life.

This description comes directly from the study's public registry record.

Talk to the study team

Jacqueline KY Yuen, Dr  ·  (852) 2255-4608  ·  jkyuen@hku.hk

Always discuss trial participation with your own doctor first.

Locations (1)

Queen Mary HospitalHong Kong, Hong KongRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06799936